Skip to main content
Premium Trial:

Request an Annual Quote

Venkatraman Ramakrishnan to Lead Royal Society

Structural biologist Venkatraman Ramakrishnan has been named the next president of the UK Royal Society, Nature News reports. He will take over from Paul Nurse at the beginning of December.

"It's a great honor," Ramakrishnan tells Nature. "Paul has been an articulate and forceful advocate for science, and I can only do my best to continue that."

Ramakrishnan won the Nobel Prize in Chemistry in 2009 for his work studying ribosome and how it translates nucleic acids into proteins. While he won a Nobel in chemistry, Nature notes that Ramakrishnan's doctoral work was in physics before he changed gears to move into biology. He says this "breadth is something I hope will help me."

Additionally, Ramakrishnan grew up in India and did much of his training in the United States before coming to the UK, and Nature says these international connections may also help him expand the Royal Society's connections.

"Venki embodies the cosmopolitan nature of contemporary science," says James Wilsdon, a science-policy researcher at the University of Sussex.

Currently, Ramakrishnan is serving as the deputy director of the Medical Research Council Laboratory for Molecular Biology.

Filed under

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.